MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 184 filers reported holding MANNKIND CORP in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202 | -5.6% | 48,870 | -7.9% | 0.04% | -2.4% |
| Q2 2023 | $214 | +3.4% | 53,070 | +4.9% | 0.04% | -4.5% |
| Q1 2023 | $207 | +1.0% | 50,570 | +31.1% | 0.04% | -10.2% |
| Q4 2022 | $205 | -99.8% | 38,570 | -5.9% | 0.05% | +53.1% |
| Q3 2022 | $125,000 | -11.3% | 40,970 | +9.9% | 0.03% | -8.6% |
| Q2 2022 | $141,000 | +281.1% | 37,270 | +272.7% | 0.04% | +191.7% |
| Q1 2022 | $37,000 | -15.9% | 10,000 | 0.0% | 0.01% | -7.7% |
| Q4 2021 | $44,000 | -74.7% | 10,000 | -75.0% | 0.01% | -76.8% |
| Q3 2021 | $174,000 | -20.2% | 40,000 | 0.0% | 0.06% | -17.6% |
| Q2 2021 | $218,000 | +65.2% | 40,000 | +19.2% | 0.07% | +119.4% |
| Q1 2021 | $132,000 | +169.4% | 33,570 | +115.6% | 0.03% | +158.3% |
| Q4 2020 | $49,000 | +104.2% | 15,570 | +23.9% | 0.01% | +71.4% |
| Q3 2020 | $24,000 | +9.1% | 12,570 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $22,000 | – | 12,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 533,828 | $2,333,000 | 1.15% |
| 180 WEALTH ADVISORS, LLC | 1,037,426 | $3,932,000 | 0.88% |
| EMERALD ADVISERS, LLC | 5,217,037 | $22,798,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 4,648,971 | $20,316,000 | 0.72% |
| Avoro Capital Advisors LLC | 8,800,000 | $38,456,000 | 0.65% |
| Monarch Partners Asset Management LLC | 420,478 | $1,837,000 | 0.37% |
| DG Capital Management, LLC | 511,562 | $2,236,000 | 0.37% |
| Bruce & Co., Inc. | 395,073 | $1,726,000 | 0.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $3,037,000 | 0.29% |
| Parkman Healthcare Partners LLC | 265,855 | $1,162,000 | 0.26% |